Expert Radar
Dr. Mark Hunter, MD
Dr. Mark Hunter, MD
University of California Irvine Medical Center
Bachelor of Science, Arizona State University
Dr. Mark I. Hunter has 14 years of experience in the field of Gynecologic Oncology. He earned his BS in Engineering from Arizona State University and his MD from David Geffen School of Medicine at UCLA. He completed his residency in Obstetrics and Gynecology and his fellowship in Gynecologic Oncology at the University of California Irvine Medical Center. Today, this expert is board certified in Gynecologic Oncology and Obstetrics & Gynecology. Formerly, he served as an Assistant Professor at the University of Missouri School of Medicine and as a Clinical Instructor at the University of California Irvine, School of Medicine. Currently, he serves as the Director of Gynecologic Oncology at MU Health Care Ellis Fischel Cancer Center and as an Associate Professor of Clinical Obstetrics and Gynecology at the University of Missouri School of Medicine.
h*********@******.missouri
(573) ***-****
Columbia, Missouri
Get a FREE Demo of Dr. Mark Hunter, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
32
Media & News
241
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|---|---|
Robert Futoran, M.D. vs. Sunrise Mountainview Hospital, Inc., et al. | Expert Witness | 2016-01-29 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 32 records
Title | Type |
|---|---|
ERBB2 Targeting Reveals a Significant Suppression of Tumorigenesis in Murine Endometrial Cancer with Pten Mutation | Journal Article |
ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer | Journal Article |
Periostin’s role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma | Review |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 241 records
Title | Description |
|---|
Unlock Dr. Mark Hunter, MD's full profile
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
Arizona State University | Bachelor of Science |
David Geffen School of Medicine at UCLA | Doctor of Medicine |
Work History
Title | Employer |
|---|---|
— | University of California Irvine Medical Center |
— | University of California Irvine Medical Center |
Associate Professor | University of Missouri School of Medicine (Columbia, MO) |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
